Transplacental passage of insulin complexed to antibody
- PMID: 7027265
- PMCID: PMC319838
- DOI: 10.1073/pnas.78.7.4588
Transplacental passage of insulin complexed to antibody
Abstract
The passage of plasma proteins across the placental barrier in humans is known to be highly selective. Thus, free maternal insulin has been reported not to cross the normal maternofetal barrier, although insulin-binding antibodies have been detected in newborn infants whose diabetic mothers received insulin therapy. In this report we demonstrate, with the use of a human antiserum that permits distinction between human and animal insulins, that insulin in the cord blood of each of two neonates of insulin-treated diabetic mothers was, in part, animal insulin. The higher the antibody titer of the mother the greater was the total insulin in the cord plasma and the greater was the fraction that was animal insulin. In case 1 cord plasma insulin was 0.7 unit/liter, of which 10% was animal insulin; in case 2 cord plasma insulin was 3.5 units/liter, of which 25% was animal insulin. The demonstration that antigen restricted from transplacental passage can be transferred while complexed to antibody raises the question whether such fetal exposure would induce partial or total immunologic unresponsiveness subsequently if the fetus were rechallenged with the same antigen.
Similar articles
-
Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia.N Engl J Med. 1990 Aug 2;323(5):309-15. doi: 10.1056/NEJM199008023230505. N Engl J Med. 1990. PMID: 2195347
-
Insulin immunogenicity in pregnancy: maternal and fetal studies.Diabetologia. 1983 Jan;24(1):19-25. doi: 10.1007/BF00275942. Diabetologia. 1983. PMID: 6186558
-
Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies.J Soc Gynecol Investig. 1996 Mar-Apr;3(2):78-84. J Soc Gynecol Investig. 1996. PMID: 8796812
-
Diabetic pregnancy, maternal and fetal docosahexaenoic acid: a review of existing evidence.J Matern Fetal Neonatal Med. 2018 May;31(10):1358-1363. doi: 10.1080/14767058.2017.1314460. Epub 2017 Apr 19. J Matern Fetal Neonatal Med. 2018. PMID: 28423959 Review.
-
The immunogenicity of new insulins.Diabetes. 1985 Jun;34 Suppl 2:94-6. doi: 10.2337/diab.34.2.s94. Diabetes. 1985. PMID: 3888748 Review.
Cited by
-
Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model.PLoS One. 2009 Nov 24;4(11):e7986. doi: 10.1371/journal.pone.0007986. PLoS One. 2009. PMID: 19956710 Free PMC article.
-
Management of diabetic pregnancy.Postgrad Med J. 1994 Sep;70(827):610-9. doi: 10.1136/pgmj.70.827.610. Postgrad Med J. 1994. PMID: 7971624 Free PMC article. Review. No abstract available.
-
Neonatal diabetes mellitus.Endocr Rev. 2008 May;29(3):265-91. doi: 10.1210/er.2007-0029. Epub 2008 Apr 24. Endocr Rev. 2008. PMID: 18436707 Free PMC article. Review.
-
Role of insulin in the fetus.Indian J Pediatr. 1991 Jan-Feb;58(1):31-5. doi: 10.1007/BF02810407. Indian J Pediatr. 1991. PMID: 1937627 Review. No abstract available.
-
Abnormal ambient glucose levels inhibit proteoglycan core protein gene expression and reduce proteoglycan accumulation during chondrogenesis: possible mechanism for teratogenic effects of maternal diabetes.Proc Natl Acad Sci U S A. 1989 Dec;86(24):10113-7. doi: 10.1073/pnas.86.24.10113. Proc Natl Acad Sci U S A. 1989. PMID: 2602360 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical